An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic – Wiley

1 INTRODUCTION
Several countries have reported declining cancer diagnosis registrations following the COVID19 outbreak and flagged this as an imminent policy concern, because it implies substantially delayed cancer diagnoses. For example, the Netherlands Cancer Registry has presented weekly cancer incidence estimates since the outbreak of COVID19. At the peak of the outbreak, cancer incidence for all cancers combined was 40% lower on average compared to historical data, with the incidence rate for…

Click here to view the original article.